These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 12970322)

  • 1. Involvement of the PAX8/peroxisome proliferator-activated receptor gamma rearrangement in follicular thyroid tumors.
    Dwight T; Thoppe SR; Foukakis T; Lui WO; Wallin G; Höög A; Frisk T; Larsson C; Zedenius J
    J Clin Endocrinol Metab; 2003 Sep; 88(9):4440-5. PubMed ID: 12970322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.
    Marques AR; Espadinha C; Catarino AL; Moniz S; Pereira T; Sobrinho LG; Leite V
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3947-52. PubMed ID: 12161538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.
    Cheung L; Messina M; Gill A; Clarkson A; Learoyd D; Delbridge L; Wentworth J; Philips J; Clifton-Bligh R; Robinson BG
    J Clin Endocrinol Metab; 2003 Jan; 88(1):354-7. PubMed ID: 12519876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PAX8 and peroxisome proliferator-activated receptor gamma 1 gene expression status in benign and malignant thyroid tissues.
    Lacroix L; Mian C; Barrier T; Talbot M; Caillou B; Schlumberger M; Bidart JM
    Eur J Endocrinol; 2004 Sep; 151(3):367-74. PubMed ID: 15362967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RAS point mutations and PAX8-PPAR gamma rearrangement in thyroid tumors: evidence for distinct molecular pathways in thyroid follicular carcinoma.
    Nikiforova MN; Lynch RA; Biddinger PW; Alexander EK; Dorn GW; Tallini G; Kroll TG; Nikiforov YE
    J Clin Endocrinol Metab; 2003 May; 88(5):2318-26. PubMed ID: 12727991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is thyroid follicular cancer in Japanese caused by a specific t(2; 3)(q13; p25) translocation generating Pax8-PPAR gamma fusion mRNA?
    Hibi Y; Nagaya T; Kambe F; Imai T; Funahashi H; Nakao A; Seo H
    Endocr J; 2004 Jun; 51(3):361-6. PubMed ID: 15256783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma.
    Castro P; Rebocho AP; Soares RJ; Magalhães J; Roque L; Trovisco V; Vieira de Castro I; Cardoso-de-Oliveira M; Fonseca E; Soares P; Sobrinho-Simões M
    J Clin Endocrinol Metab; 2006 Jan; 91(1):213-20. PubMed ID: 16219715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peroxisome proliferator-activated receptor gamma expression in follicular-patterned thyroid lesions. Caveats for the use of immunohistochemical studies.
    Gustafson KS; LiVolsi VA; Furth EE; Pasha TL; Putt ME; Baloch ZW
    Am J Clin Pathol; 2003 Aug; 120(2):175-81. PubMed ID: 12931546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic and biological subgroups of low-stage follicular thyroid cancer.
    French CA; Alexander EK; Cibas ES; Nose V; Laguette J; Faquin W; Garber J; Moore F; Fletcher JA; Larsen PR; Kroll TG
    Am J Pathol; 2003 Apr; 162(4):1053-60. PubMed ID: 12651598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAX8-PPARgamma rearrangement in thyroid tumors: RT-PCR and immunohistochemical analyses.
    Nikiforova MN; Biddinger PW; Caudill CM; Kroll TG; Nikiforov YE
    Am J Surg Pathol; 2002 Aug; 26(8):1016-23. PubMed ID: 12170088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Underexpression of peroxisome proliferator-activated receptor (PPAR)gamma in PAX8/PPARgamma-negative thyroid tumours.
    Marques AR; Espadinha C; Frias MJ; Roque L; Catarino AL; Sobrinho LG; Leite V
    Br J Cancer; 2004 Aug; 91(4):732-8. PubMed ID: 15238980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delineation, functional validation, and bioinformatic evaluation of gene expression in thyroid follicular carcinomas with the PAX8-PPARG translocation.
    Giordano TJ; Au AY; Kuick R; Thomas DG; Rhodes DR; Wilhelm KG; Vinco M; Misek DE; Sanders D; Zhu Z; Ciampi R; Hanash S; Chinnaiyan A; Clifton-Bligh RJ; Robinson BG; Nikiforov YE; Koenig RJ
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):1983-93. PubMed ID: 16609007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for a 3p25 breakpoint hot spot region in thyroid tumors of follicular origin.
    Drieschner N; Belge G; Rippe V; Meiboom M; Loeschke S; Bullerdiek J
    Thyroid; 2006 Nov; 16(11):1091-6. PubMed ID: 17123335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAX8-PPARgamma1 fusion oncogene in human thyroid carcinoma [corrected].
    Kroll TG; Sarraf P; Pecciarini L; Chen CJ; Mueller E; Spiegelman BM; Fletcher JA
    Science; 2000 Aug; 289(5483):1357-60. PubMed ID: 10958784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor gamma is frequently downregulated in a diversity of sporadic nonmedullary thyroid carcinomas.
    Aldred MA; Morrison C; Gimm O; Hoang-Vu C; Krause U; Dralle H; Jhiang S; Eng C
    Oncogene; 2003 May; 22(22):3412-6. PubMed ID: 12776192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of peroxisome poliferator-activated receptor gamma on thyroid carcinoma cell growth.
    Martelli ML; Iuliano R; Le Pera I; Sama' I; Monaco C; Cammarota S; Kroll T; Chiariotti L; Santoro M; Fusco A
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4728-35. PubMed ID: 12364466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Follicular thyroid tumors with the PAX8-PPARgamma1 rearrangement display characteristic genetic alterations.
    Lacroix L; Lazar V; Michiels S; Ripoche H; Dessen P; Talbot M; Caillou B; Levillain JP; Schlumberger M; Bidart JM
    Am J Pathol; 2005 Jul; 167(1):223-31. PubMed ID: 15972966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a paired box gene 8-peroxisome proliferator-activated receptor gamma (PAX8-PPARgamma) rearrangement mosaicism in a patient with an autonomous functioning follicular thyroid carcinoma bearing an activating mutation in the TSH receptor.
    Lado-Abeal J; Celestino R; Bravo SB; Garcia-Rendueles ME; de la Calzada J; Castro I; Castro P; Espadinha C; Palos F; Soares P; Alvarez CV; Sobrinho-Simões M; Cameselle-Teijeiro J
    Endocr Relat Cancer; 2010 Sep; 17(3):599-610. PubMed ID: 20427420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence in situ hybridization analysis using PAX8- and PPARG-specific probes reveals the presence of PAX8-PPARG translocation and 3p25 aneusomy in follicular thyroid neoplasms.
    Chia WK; Sharifah NA; Reena RM; Zubaidah Z; Clarence-Ko CH; Rohaizak M; Naqiyah I; Srijit D; Hisham AN; Asmiati A; Rafie MK
    Cancer Genet Cytogenet; 2010 Jan; 196(1):7-13. PubMed ID: 19963130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the prevalence of the PAX8-PPARG fusion resulting from the chromosomal translocation t(2;3)(q13;p25) in adenomas of the thyroid.
    Klemke M; Drieschner N; Laabs A; Rippe V; Belge G; Bullerdiek J; Sendt W
    Cancer Genet; 2011 Jun; 204(6):334-9. PubMed ID: 21763631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.